Kathy Ireland has invested in St. Louis‑based AI firm Capacity as it advances a Series E round, bringing a high‑profile backer to the city’s tech scene.

Gov. Jared Polis urged Coloradans to weigh in on an NSF review that could reshape NCAR. Public comments are due today and the agency says responses will inform next steps.

A Duke‑led study in Forsyth County is testing drones that deliver AEDs to 911 cardiac‑arrest calls, lowering devices to bystanders while EMS heads to the scene.

A viral cellphone clip from Corona shows three glowing orbs moving in a triangular pattern. Authorities say corroborating radar or sensor data are needed to identify the sighting.

A La Jolla immunologist helped identify tiny food protein fragments that tell gut immune cells to tolerate corn, wheat and soy — a finding that could inform future allergy therapies.

Texas Tech researchers used ATR‑FTIR and Raman spectroscopy with machine learning to identify fentanyl exposure in fingernail clippings, a noninvasive method presented at Pittcon.

An investigation ties contaminated medicines, falsified testing and inspection gaps to overseas factories — and patients are already paying the price.

State regulators approved the Dawn Harvest solar and battery project in Rock County. We Energies will be majority owner and the facility is expected to start serving customers in 2028.

Mass General Brigham landed a $50 million anonymous gift to expand gene and cell therapy research and clinical trials across the system.

Genomic surveys show scarlet monkeyflower evolved drought‑tolerant genes during California’s 2012–2015 megadrought, helping some populations recover — a rare example of evolutionary rescue.

Dr. Jeff Balser announced his retirement from Vanderbilt University Medical Center on March 12, 2026, ending a long tenure leading Nashville’s largest hospital system.

A falling out between two Denver bitcoin veterans centers on a 2018 69.8 BTC loan and a claim the contract is forged. The matter is now in arbitration and court.

Danish biotech Zealand Pharma is opening a Boston research hub to speed obesity drug discovery and expects to hire about 50–100 staff.